We’ve talked quite a bit about Fuentek’s philosophy of a phased, step-by-step approach to many aspects of technology commercialization. Case in point: we begin by screening whether a technology is fit for commercialization before ramping up for marketing. With this approach, we invest as few resources as necessary in weeding out technologies that are far from ready for commercialization to quickly and cost-efficiently find the golden apples that are ripe for licensing.
We know that not all technology transfer deals are created equal. And in some cases, the estimated value of a deal can appear to be so low that it’s not worth going after. So how do you know when to abandon the negotiation and when to push for a more lucrative deal? That’s the focus of this Story from the Field. A prospect was interested in licensing our client’s technology, but in the course of qualifying the prospect, Fuentek learned that the company’s rough estimates of sales would yield very little royalty revenue—approximately $3K per year. This low value was hardly worth the effort of negotiating a licensing agreement, so we saw two options…
Thanks to Fuentek’s social media efforts, our inbound leads for client technologies have been going up dramatically, as have the leads coming in through more traditional marketing mechanisms. I get so excited every time we generate a new lead for one of our customers! But as exciting as that is, we always take a step back and qualify the lead.
I am all in favor of streamlining in licensing activities, and standard agreements are definitely a useful tool. But they are best when used judiciously and in certain specific situations rather than taking a one-size-fits-all approach.
Negotiating royalties is challenging under the best of circumstances. In this post, I outline several real-world examples of successes, near-failures, and collapsed deals.
A large part of successful technology licensing is remembering that one size does not fit all when it comes to structuring royalty rates. Sure, standardization can help streamline your work. But in some cases, you have to take a creative approach in order to secure the deal.
As one of the most important discoveries in the field of applied mathematics in NASA history, HHT is a revolutionary, adaptive set of signal-analysis algorithms. This innovation had great commercialization success with multiple licenses and more than 400 Software Usage Agreements. Fuentek played a major role in the successful commercialization of NASA’s HHT technology.
I’ve said it before, and I’ll say it again: You have to be patient when it comes to technology licensing—especially if you’re talking about commercialization of an innovation for medical use. Yesterday, in conjunction with Breast Cancer Awareness Month …
Metrics are one of the most challenging aspects of licensing that any technology transfer office (TTO) faces when pursuing commercialization of intellectual property. And yet they’re one of the most important.
Editor’s note: This is the fifth in a six-post series on how Fuentek views technology licensing through a new PRISM. Many people cite Winston Churchill as saying that “Consistency is the hobgoblin of little minds.” But there is a key word they’re leavi …